Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)
NCT07541833 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2026-04-21
Summary
The purpose of this study is to assess the real-world effectiveness and safety of mavacamten in adults diagnosed with symptomatic obstructive hypertrophic cardiomyopathy (HOCM) receiving cibenzoline in Japan
Conditions
Interventions
- DRUG
-
According to the product label
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristo Myers Squibb · Bristo Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-05
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
- FDA Drug
- Yes
Countries
- Japan
Study Locations
More Related Trials
-
Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm
NCT01022463 ·Status: COMPLETED ·Phase: PHASE3
-
Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy
NCT05366101 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease
NCT03887013 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome
NCT00429364 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure
NCT02391142 ·Status: UNKNOWN ·Phase: NA
-
Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function
NCT01961453 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.
NCT01284868 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients
NCT00200473 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris
NCT04270279 ·Status: UNKNOWN ·Phase: PHASE4
-
Cognitive/Cerebrovascular Consequences of HTN Treatment
NCT00151138 ·Status: COMPLETED ·Phase: NA
-
Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?
NCT01605370 ·Status: TERMINATED ·Phase: PHASE4
-
Echocardiographic Study of a Single Dose Bisoprolol Versus Nebivolol in Healthy Subjects
NCT04432610 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy
NCT04133532 ·Status: COMPLETED ·Phase: PHASE4
-
To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina
NCT02623569 ·Status: UNKNOWN ·Phase: PHASE2
-
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
NCT01648634 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients
NCT01213173 ·Status: COMPLETED ·Phase: PHASE4
-
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
NCT05593055 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma
NCT03633747 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)
NCT04197453 ·Status: TERMINATED
-
Comparison of Efficacy of Ivabradine Versus Metoprolol
NCT01755663 ·Status: UNKNOWN ·Phase: PHASE4
-
Cardiac Denervation Ablation Strategy for Severe Sinus Bradycardia
NCT06276816 ·Status: RECRUITING
-
Effect of NT-proBNP Guided Treatment of Chronic Heart Failure
NCT00149422 ·Status: COMPLETED ·Phase: NA
-
Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock
NCT07562932 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma
NCT05106179 ·Status: UNKNOWN ·Phase: PHASE4
-
Molecular Mechanisms of Volume Overload-Aim 1(SCCOR in Cardiac Dysfunction and Disease)
NCT01052428 ·Status: COMPLETED ·Phase: PHASE2/PHASE3